Hemoglobin–albumin cross-linking with disuccinimidyl suberate (DSS) and/or glutaraldehyde for blood substitutes

References

• Alayash AI. 2004. Oxygen therapeutics: can we tame haemoglobin?. Nat Rev Drug Discov. 3:152–159.
   PubMed Web of Science ®Google Scholar
• Antonini E, Brunori M. 1971. Hemoglobin and Myoglobin in Their Reaction with Ligands. Frontiers in Biology. North-Holland, Amsterdam.
   Google Scholar
• Caron A, Menu P, Faivre-Fiorina B, Labrude P, Alayash AI, Vigneron C. 1999. Cardiovascular and hemorheological effects of three modified human hemoglobin solutions in hemodiluted rabbits. J Appl Physiol. 86:541–548.
   PubMed Web of Science ®Google Scholar
• Chang TM. 2004. Hemoglobin-based red blood cell substitutes. Artif Organs. 28:789–794.
   PubMed Web of Science ®Google Scholar
• Chang TMS. 2009. Nanobiotechnology for hemoglobin based blood substitutes. Crit Care Clinics. 25:373–382.
   PubMed Web of Science ®Google Scholar
• Chen JY, Scerbo M, Kramer G. 2009. A review of blood substitutes: examining the history, clinical trial results, and ethics of hemoglobin-based oxygen carriers. Clinics (Sao Paulo). 64:803–813.
   PubMed Web of Science ®Google Scholar
• Deac F, Lacob B, Fischer-Fodor E, Damian G, Silaghi-Dumitrescu R. 2011. Derivatization of hemoglobin with periodate-generated reticulation agents: evaluation of oxidative reactivity for potential blood substitutes. J Biochem (Tokyo). 149:75–82.
   PubMed Web of Science ®Google Scholar
• Deac F, Todea A, Silaghi-Dumitrescu R. 2009. Glutaraldehyde derivatization of hemoglobin: a potential blood substitute. In: Silaghi-Dumitrescu R, Garban G, Eds. Metal Elements in Environment, Medicine and Biology Tome IX. Cluj-Napoca, Romania: Cluj University Press, pp. 165–173.
   Google Scholar
• Deac FV, Bolfa AM, Magdas C, Sevastre B, Turc S, Silaghi-Dumitrescu R. 2010. Hemoglobin-based blood substitutes: which hemoglobin to use?. Rom J Biochem. 47:135–141.
   Web of Science ®Google Scholar
• Doherty DH, Doyle MP, Curry SR, Vali RJ, Fattor TJ, Olson JS, Lemon DD. 1998. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nat Biotechnol 16:672–676.
   PubMed Web of Science ®Google Scholar
• Fedorov AN, Iarochkin VS, Koziner VB, Hachaturian AA, Rozenberg GI. 1978. Support of respiration and hemodynamics by complete blood replacement with artificial oxygen carriers: polyhemoglobinalbumin and polyhemoglobin. Dokl Akad Nauk SSSR. 243:1324–1326.
   PubMedGoogle Scholar
• Harris DR, Palmer AF. 2008. Modern cross-linking strategies for synthesizing acellular hemoglobin-based oxygen carriers. Biotechnol Prog. 24:1215–1225.
   PubMed Web of Science ®Google Scholar
• Kratz F. 2008. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Contr Release. 132:171–183.
   PubMed Web of Science ®Google Scholar
• Lacob B, Deac F, Cioloboc D, Damian G, Silaghi-Dumitrescu R. 2011. Hemoglobin-albumin crosslinked copolymers: reduced prooxidant reactivity. Artif Cells Blood Substit Immobil Biotechnol 39:293–297.
   PubMedGoogle Scholar
• Lu X, Zheng C, Xu Y, Su Z. 2005. Disuccinimidyl suberate cross-linked hemoglobin as a novel red blood cell substitute Sci China C Life Sci. 48:49–60.
   Google Scholar
• Pilch PF, Czech MP. 1979. Interaction of crosslinking agents with the insulin effector system of isolated fat cells. J Biol Chem. 254: 3375–3381.
   PubMed Web of Science ®Google Scholar
• Portoro I, Kocsis L, Herman P, Caccia D, Perrella M, Ronda L, et al. 2008. Towards a novel haemoglobin-based oxygen carrier: Euro-PEG-Hb, physico-chemical properties, vasoactivity and renal filtration. Biochim Biophys Acta. 1784:1402–1409.
   PubMed Web of Science ®Google Scholar
• Reeder BJ, Grey M, Silaghi-Dumitrescu RL, Svistunenko DA, Bulow L, Cooper CE, Wilson MT. 2008. Tyrosine residues as redox cofactors in human hemoglobin: implications for engineering nontoxic blood substitutes. J Biol Chem. 283:30780–30787.
   PubMed Web of Science ®Google Scholar
• Reeder BJ, Svistunenko DA, Cooper CE, Wilson MT. 2004. The radical and redox chemistry of myoglobin and hemoglobin: from in vitro studies to human pathology. Antioxid. Redox Sign. 6:954–966.
   PubMed Web of Science ®Google Scholar
• Svistunenko DA. 2005. Reaction of haem containing proteins and enzymes with hydroperoxides: the radical view. Biochim Biophys Acta. 1707:127–155.
   PubMed Web of Science ®Google Scholar
• Trynda-Lemiesz L, Luczkowski M. 2004. Human serum albumin: spectroscopies studies of the paclitaxel binding and proximity relationship with cisplatin and Adriamycin. J Inorg Biochem. 98:1851–1856.
   PubMed Web of Science ®Google Scholar
• Tsuchida E, Sou K, Nakagawa A, Sakai H, Komatsu T, Kobayashi K. 2009. Artificial oxygen carriers, hemoglobin vesicles and albumin-hemes, based on bioconjugate chemistry. Bioconjug Chem. 20:1419–1440.
   PubMed Web of Science ®Google Scholar
• Winslow RM. 2004. MP4, a new nonvasoactive polyethylene glycol-hemoglobin conjugate. Artif Organs. 28:800–806.
   PubMed Web of Science ®Google Scholar
• Yue Y, Chen X, Qin J, Yao X. 2009. Spectroscopic investigation on the binding of antineoplastic drug oxaliplatin to human serum albumin and molecular modeling. Colloids Surfaces B. 69:51–57.
   PubMed Web of Science ®Google Scholar
• Zolog O, Mot A, Deac F, Roman A, Fischer-Fodor E, Silaghi-Dumitrescu R. 2011. A new polyethyleneglycol-derivatized hemoglobin derivative with decreased oxygen affinity and limited toxicity. Protein J. 30:27–31.
   PubMed Web of Science ®Google Scholar